Lou Yu Yan
Director/Board Member en ESLITE SPECTRUM CORPORATION .
Perfil
Lou Yu Yan currently works at Qisda Corp., as Independent Director from 2020, Sinyi Realty, Inc., as Independent Director from 2017, ANZ Banking Corp., as Independent Director, and The Eslite Spectrum Corp., as Independent Director.
Mr. Yan also formerly worked at Chunghwa Telecom Co., Ltd., as Independent Director and Crown Bioscience International, as Independent Director.
Mr. Yan received his graduate degree from National Chengchi University.
Cargos activos de Lou Yu Yan
Empresas | Cargo | Inicio |
---|---|---|
ESLITE SPECTRUM CORPORATION | Director/Board Member | - |
SINYI REALTY INC. | Director/Board Member | 26/05/2017 |
QISDA CORPORATION | Director/Board Member | 19/06/2020 |
ANZ Banking Corp.
ANZ Banking Corp. Regional BanksFinance ANZ Banking Corp. provides commercial banking services. The company is headquartered in Northcote, Australia. | Director/Board Member | - |
Antiguos cargos conocidos de Lou Yu Yan.
Empresas | Cargo | Fin |
---|---|---|
CHUNGHWA TELECOM CO., LTD. | Director/Board Member | - |
CROWN BIOSCIENCE INTERNATIONAL | Director/Board Member | - |
Formación de Lou Yu Yan.
National Chengchi University | Graduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
CHUNGHWA TELECOM CO., LTD. | Communications |
QISDA CORPORATION | Electronic Technology |
SINYI REALTY INC. | Finance |
ESLITE SPECTRUM CORPORATION | Finance |
Empresas privadas | 2 |
---|---|
ANZ Banking Corp.
ANZ Banking Corp. Regional BanksFinance ANZ Banking Corp. provides commercial banking services. The company is headquartered in Northcote, Australia. | Finance |
Crown Bioscience International
Crown Bioscience International BiotechnologyHealth Technology Crown Bioscience International develops drug for Oncology and Metabolic Diseases. Its products include Antibodies for in vivo & in vitro studies, Tissues for CVMD research and therapeutic R&D, Recombinant cell lines, Tumor samples for oncology research & drug development. The company founded on October 22, 2013 and is headquartered in Taipei, Taiwan. | Health Technology |
- Bolsa de valores
- Insiders
- Lou Yu Yan